bsi-045b
Showing 1 - 1 of 1
Atopic Dermatitis Trial in Newark (BSI-045B, Dupilumab)
Not yet recruiting
- Atopic Dermatitis
- BSI-045B
- Dupilumab
-
Newark, DelawareBiosion USA, Inc.
Jul 7, 2023